General Information of the Compound
Compound ID
CP0497630
Compound Name
2-(3-(4-(2-(3,5-dichlorophenoxy)ethylcarbamoyl)-5-phenylisoxazol-3-yl)phenyl)acetic acid
    Show/Hide
Structure
Formula
C26H20Cl2N2O5
Molecular Weight
511.361
Canonical SMILES
OC(=O)Cc1cccc(c1)-c1noc(c1C(=O)NCCOc1cc(Cl)cc(Cl)c1)-c1ccccc1
    Show/Hide
InChI
InChI=1S/C26H20Cl2N2O5/c27-19-13-20(28)15-21(14-19)34-10-9-29-26(33)23-24(18-8-4-5-16(11-18)12-22(31)32)30-35-25(23)17-6-2-1-3-7-17/h1-8,11,13-15H,9-10,12H2,(H,29,33)(H,31,32)
    Show/Hide
InChIKey
GCTNYGSNXGCPAZ-UHFFFAOYSA-N
Physicochemical Property
logP
5.7513
Rotatable Bonds
9
Heavy Atom Count
35
Polar Areas
101.66
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
35

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46878644
ChEMBL ID
CHEMBL1075665
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
Protein ID: PT00909, Peroxisome proliferator-activated receptor delta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
EC50 = 70 nM
   TI
   LI
   LO
   TS
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS